Acumen Pharmaceuticals, Inc. (ABOS): Price and Financial Metrics

Acumen Pharmaceuticals, Inc. (ABOS): $1.45

0.01 (-0.68%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add ABOS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#223 of 337

in industry

ABOS Price/Volume Stats

Current price $1.45 52-week high $5.09
Prev. close $1.46 52-week low $1.28
Day low $1.43 Volume 162,100
Day high $1.51 Avg. volume 299,503
50-day MA $1.75 Dividend yield N/A
200-day MA $2.51 Market Cap 87.12M

ABOS Stock Price Chart Interactive Chart >


Acumen Pharmaceuticals, Inc. (ABOS) Company Bio


Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.


ABOS Latest News Stream


Event/Time News Detail
Loading, please wait...

ABOS Latest Social Stream


Loading social stream, please wait...

View Full ABOS Social Stream

ABOS Price Returns

1-mo -12.12%
3-mo -35.27%
6-mo -48.76%
1-year -55.79%
3-year -74.78%
5-year N/A
YTD -15.70%
2024 -55.21%
2023 -28.89%
2022 -20.12%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!